PhageNova Bio Competitors and Similar CompaniesClear all
ARIAD Pharmaceuticals's competitors and similar companies include Exelixis.
 ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. | ||
Founding Date | Founding Date 1991 | Founding Date 1994 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more | Locations Alameda, US HQ |
Employees | Employees 1381% increase | Employees 1,14712% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $118.8m (FY, 2015) | Revenue (est.) $2.3b (FY, 2025) |
Cost of goods | Cost of goods $2.1m (FY, 2015) | Cost of goods $83.7m (FY, 2025) |
Gross profit | Gross profit $116.7m (FY, 2015) | Gross profit $2.2b (FY, 2025) |
Net income | Net income ($231.2m) (FY, 2015) | Net income $782.6m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View company